Goldshore Resources Inc. (GSHRF)

OTCMKTS · Delayed Price · Currency is USD
0.3084
-0.0066 (-2.10%)
Aug 1, 2025, 2:08 PM EDT

Verve Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2023FY 2022FY 2021
Period Ending
Aug '25 Dec '24 Dec '23 Mar '23 Mar '22 Mar '21
14758232044-
Market Cap Growth
152.09%156.66%13.90%-55.28%--
Enterprise Value
13954211732-
Last Close Price
0.310.170.090.120.38-
PB Ratio
2.250.900.360.360.86-
P/TBV Ratio
2.250.900.360.360.86-
Debt / Equity Ratio
0.000.000.000.000.010.01
Quick Ratio
3.363.207.280.733.620.15
Current Ratio
3.443.257.400.913.751.17
Return on Equity (ROE)
-8.15%-6.84%--10.15%-39.57%-
Return on Assets (ROA)
-2.62%-2.18%--2.85%-6.39%-
Return on Capital (ROIC)
-3.09%-2.57%--3.34%-8.77%-
Earnings Yield
-3.40%-7.16%-14.73%-26.14%-24.32%-
FCF Yield
-6.90%-9.76%-28.88%-99.07%-41.78%-
Buyback Yield / Dilution
-34.84%-40.53%-37.06%-66.11%-569.45%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.